Pechevis M, Fagnani F, Brin S, De Zelicourt M, Morales M
CEMKA, Bourg-la-Reine.
Rev Mal Respir. 1996 Oct;13(5):507-12.
The objective of this study is to describe usual medical management and costs associated with recurrent respiratory infections in subjects with chronic obstructive bronchitis in France. A prospective survey was performed in Autumn 1994 on a national sample of private practice pulmonologists (N = 71). Two hundred forty-four patients, presenting at least one infection of the lower respiratory tract, were included. Bronchitis was the most frequent acute exacerbation observed (94%). Pneumonia concerned 9% of the patients. Biological tests, X-rays and pulmonary function tests were prescribed for, respectively, 59, 65 and 45% of the patients. Following the visit, 15 patients were hospitalized (6%). The direct medical cost per acute exacerbation was estimated 3,289 francs (1994 value) of which 60% were hospital-related. An average 10.4 day sick-leave was prescribed to 21% of patients in employment. For those patients, this sick-leave was associated to an extra-cost of 1,264-1,876 francs for Social Security and of 0-2,553 francs out of pocket per episode varying according to their Benefit Regimen.
本研究的目的是描述法国慢性阻塞性支气管炎患者反复呼吸道感染的常规医疗管理及相关费用。1994年秋季,对全国范围内的私人执业肺科医生样本(N = 71)进行了一项前瞻性调查。纳入了244例至少有一次下呼吸道感染的患者。观察到的最常见急性加重为支气管炎(94%)。肺炎患者占9%。分别有59%、65%和45%的患者接受了生物检查、X光检查和肺功能检查。就诊后,15例患者住院(6%)。每次急性加重的直接医疗费用估计为3289法郎(1994年价值),其中60%与住院相关。21%的在职患者平均被开具了10.4天的病假。对于这些患者,根据其福利制度不同,每次病假给社会保障带来的额外费用为1264 - 1876法郎,自付费用为0 - 2553法郎。